Table 2.
Single-center outcomes of patients with ESKD receiving dialysis hospitalized with COVID-19
| Outcome | n (%) or Median (IQR) | |||
|---|---|---|---|---|
| All | No Mechanical Ventilation | Mechanical Ventilation | Died with “Do Not Intubate” Advanced Directive | |
| n | n=59 | n=40 (68%) | n=8 (14%) | n=11 (19%) |
| Total no. of inpatient hemodialysis sessions per patient | 2 (2–4) | 2 (2–4) | 2 (0–5) | 2 (0–3) |
| Received continuous RRT | 3 (5) | 0 (0) | 3 (38) | 0 (0) |
| Days between admission and intubation | — | — | 1.5 (range, 0–9) | — |
| Extubated | — | — | 3 (38) | — |
| Days between intubation and extubation, n=3 | — | — | 6 (range, 1–10) | — |
| Anti–COVID-19 therapies | ||||
| Hydroxychloroquine | 34 (58) | 21 (53) | 5 (63) | 8 (73) |
| Tocilizumab | 3 (5) | 2 (5) | 1 (13) | 0 (0) |
| Died in the hospital | 18 (31) | 1 (3) | 6 (75) | 11 (100) |
| Days between admission and death | 6 (4–14) | 15 | 13 (4–21) | 6 (4–8) |
| Discharged from hospital | 41 (69) | 39 (98) | 2 (25) | — |
| Days between admission and discharge | 8 (6–12) | 8 (5–11) | 9 and 19 | — |